Fagron (ENXTBR:FAGR) shareholders approved all resolutions at the Annual and Extraordinary General Meetings. The meetings ...

May 2026 – 6PM CET Fagron shareholders approve all proposed resolutions at the General Meetings Fagron, the leading global ...

Fagron is recalling all unexpired lots of its topical anesthesia that was distributed nationwide to hospitals, pharmacies and distributors after the FDA found possible bacterial contamination. The non ...

Rafael Padilla, CEO of Fagron: “I am proud of our strong first half performance, with all regions contributing to profitable growth. We have made meaningful operational progress, notably in product ...

MIAMI--(BUSINESS WIRE)--Fagron North America, a leading supplier of compounded medications to hospital pharmacies and patients, will open one of the largest 503B human drug outsourcing facilities in ...

Fagron agreed to pay $22.05 million to resolve allegations that its subsidiary, Freedom Pharmaceuticals, intentionally inflated average wholesale prices for its ingredients to increase reimbursements ...

Fagron, the leading global player in pharmaceutical compounding, is pleased to announce two strategic acquisitions that further strengthen its global footprint and diversify its capabilities. These ...

WICHITA, Kan. (KSNW) – A company that is seeing a lot of success in Wichita will get even bigger and hire more people. Fagron (pronounced fuh-grawn) Sterile Services (FSS) started as JCB Labs almost ...

Investing.com -- Fagron BV on Thursday reported a 6.4% increase in third-quarter revenue to €228.2 million, driven by growth in Europe and Latin America, while the U.S. Food and Drug Administration ...

* Announces that a court case was filed on July 18th against Fagron NV, Fagron Holdings USA, LLC and certain former directors of company by one of nine former owners of Anazaohealth in U.S * Former ...

The Annual General Meeting approved the annual accounts and the other annual documents for the 2025 financial year, including the distribution of a gross dividend of EUR 0.40 per share. In addition, ...